Total Payments
$471.24
2024 Payments
$16.94
Companies
13
Transactions
19
Medicare Patients
1,854
Medicare Billing
$263,564
Payment Breakdown by Category
Food & Beverage$375.24 (79.6%)
Consulting$48.00 (10.2%)
Travel$48.00 (10.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $375.24 | 17 | 79.6% |
| Travel and Lodging | $48.00 | 1 | 10.2% |
| Consulting Fee | $48.00 | 1 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sirtex Medical Inc | $168.16 | 2 | $0 (2022) |
| Foundation Medicine, Inc. | $96.00 | 2 | $0 (2018) |
| Lilly USA, LLC | $32.97 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $25.25 | 2 | $0 (2018) |
| Amgen Inc. | $24.33 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $21.32 | 2 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $17.87 | 1 | $0 (2023) |
| PFIZER INC. | $16.94 | 1 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $16.37 | 1 | $0 (2017) |
| Exelixis Inc. | $16.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.94 | 1 | PFIZER INC. ($16.94) |
| 2023 | $17.87 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($17.87) |
| 2022 | $147.87 | 1 | Sirtex Medical Inc ($147.87) |
| 2019 | $13.50 | 1 | Clinigen Inc ($13.50) |
| 2018 | $185.94 | 9 | Foundation Medicine, Inc. ($96.00) |
| 2017 | $89.12 | 6 | Lilly USA, LLC ($32.97) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Oncology | ||||||
| 06/28/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $147.87 | General |
| Category: Interventional Oncology | ||||||
| 08/30/2019 | Clinigen Inc | Proleukin (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Metastatic Renal Cell Carcinoma or Melanoma | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONACT (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Consulting Fee | Cash or cash equivalent | $48.00 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2018 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Nephrology | ||||||
| 04/12/2018 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2018 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Oncology | ||||||
| 03/01/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Oncology | ||||||
| 02/23/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2018 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $20.29 | General |
| Category: Interventional Oncology | ||||||
| 12/04/2017 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Oncology | ||||||
| 09/25/2017 | Exelixis Inc. | Cotellic (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Oncology | ||||||
| 08/25/2017 | Genentech USA, Inc. | Zelboraf (Biological), COTELLIC | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: BioOncology | ||||||
| 05/26/2017 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 04/14/2017 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Oncology | ||||||
| 03/23/2017 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 388 | 614 | $258,308 | $54,384 |
| 2022 | 6 | 436 | 772 | $318,282 | $66,144 |
| 2021 | 7 | 483 | 860 | $337,252 | $74,189 |
| 2020 | 7 | 547 | 897 | $272,023 | $68,847 |
Total Patients
1,854
Total Services
3,143
Medicare Billing
$263,564
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 113 | 218 | $87,200 | $16,967 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 170 | $68,000 | $13,539 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 46 | 51 | $22,950 | $5,926 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 40 | 40 | $26,480 | $5,716 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 32 | $14,400 | $3,789 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $11,916 | $2,472 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $9,450 | $2,331 | 24.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 24 | $5,592 | $1,619 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 23 | $7,084 | $1,182 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $5,236 | $844.35 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 97 | 267 | $110,024 | $20,635 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 178 | $73,748 | $14,068 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 58 | $25,386 | $7,063 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 42 | 42 | $27,167 | $6,522 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $16,200 | $4,139 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 32 | $13,890 | $3,561 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 43 | 61 | $18,788 | $3,151 | 16.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $10,981 | $2,684 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 43 | $13,244 | $2,198 | 16.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 38 | $8,854 | $2,121 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 111 | 295 | $122,054 | $24,004 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 192 | $77,892 | $15,440 | 19.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 61 | $23,989 | $7,353 | 30.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 44 | 44 | $24,879 | $6,818 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 59 | 101 | $28,391 | $5,581 | 19.7% |
About Dr. Jamin Morrison, M.D
Dr. Jamin Morrison, M.D is a Internal Medicine healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1902033459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamin Morrison, M.D has received a total of $471.24 in payments from pharmaceutical and medical device companies, with $16.94 received in 2024. These payments were reported across 19 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($375.24).
As a Medicare-enrolled provider, Morrison has provided services to 1,854 Medicare beneficiaries, totaling 3,143 services with total Medicare billing of $263,564. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Camden, NJ
- Active Since 06/11/2009
- Last Updated 01/16/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902033459
Products in Payments
- SIR-Spheres Microspheres (Device) $168.16
- FOUNDATIONACT (Device) $48.00
- FOUNDATIONONE LIQUID (Device) $48.00
- CYRAMZA (Drug) $32.97
- XTANDI (Drug) $25.25
- Nubeqa (Drug) $17.87
- ELIQUIS (Drug) $16.94
- Xermelo (Drug) $16.37
- Cotellic (Drug) $16.14
- Proleukin (Drug) $13.50
- Kyprolis (Biological) $12.79
- Aranesp (Biological) $11.54
- ZOLADEX (Drug) $11.54
- Zelboraf (Biological) $10.85
- Erleada (Drug) $10.66
- ZYTIGA (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Camden
Andrea Russo, Md, MD
Internal Medicine — Payments: $294,681
Internal Medicine $294,681
Peter Georges, M.d, M.D
Internal Medicine — Payments: $78,843
Internal Medicine $78,843
Dr. Sajjad Sabir, M.d, M.D
Internal Medicine — Payments: $57,782
Internal Medicine $57,782
Wissam Abouzgheib, M.d, M.D
Internal Medicine — Payments: $48,268
Internal Medicine $48,268
Theodore Plush, D.o, D.O
Internal Medicine — Payments: $12,815
Internal Medicine $12,815
Dr. Daniel Tran, Do, DO
Internal Medicine — Payments: $11,940
Internal Medicine $11,940